GlassScriptPhysician profile
Chein-Jung Lin
NPI 1346654308
$8,914.63
in general payments reported to CMS, 2019-2025
18 companies · $1,740 in 2025
The $1,740 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,139 · 2020: $617 · 2021: $403 · 2022: $1,704 · 2023: $2,743 · 2024: $568 · 2025: $1,740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,113 · Travel and Lodging: $938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,113.01 |
| Travel and Lodging | $938.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,004.58 | 2019-2025 | General - Therapies, Avvigo Guidance System, Rotapro |
| Abiomed | $1,781.77 | 2020-2025 | Impella |
| Abbott Laboratories | $618.34 | 2022-2023 | Diamondback Coronary, Amplatzer |
| Philips North America LLC | $586.13 | 2019-2020 | |
| Medtronic, INC. | $528.45 | 2022-2023 | Onyx Frontier |
| Shockwave Medical, INC | $509.96 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $391.82 | 2019-2024 | Indigo System |
| Cardiovascular Systems INC. | $320.39 | 2019-2023 | Diamondback Coronary |
| Biotronik INC. | $261.37 | 2021-2022 | |
| Medtronic Vascular, INC. | $190.14 | 2019-2020 | |
| Cvrx, INC. | $164.04 | 2022 | |
| Terumo Medical Corporation | $140.44 | 2019 | |
| Zoll Circulation INC | $128.39 | 2020-2025 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Kiniksa Pharmaceuticals, LTD. | $110.05 | 2023 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $84.99 | 2023 | Camzyos |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.74 | 2019-2025 | Lifevest |
| Cardiva Medical, INC. | $36.52 | 2025 | Savvywire |
| Amgen INC. | $14.51 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chein-Jung Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.